This site uses cookies to offer you a better browsing experience. Find out more on how we use cookies and how you can change your settings.
MoreI Accept CookiesI Refuse Cookies

Resources

Contact Us
myTeleflex.com - Order Online
Canada / Product Areas / Emergency Medicine / Intraosseous Access / Arrow™ EZ-IO™ System / Proven in the Industry

Proven1 in the Industry: The Arrow™ EZ-IO™ System

When urgent or emergent situations arise, reducing complexity and streamlining care is key. Go with The IO You Know™ — Backed by more than 15 years of clinical research and proven1 success, you can be assured of the efficacy,2 speed,3 and reliability4 of the Arrow™ EZ-IO™ System.

Clinical Study

Intraosseous vascular access is safe, effective and costs less than central venous catheters for patients in the hospital setting.

- Dolister M, Miller S, Borron S, et al.

View Study

Clinical Study

Is the intraosseous access route fast and efficacious compared to conventional central venous catheterization in adult patients under resuscitation in the emergency department? A prospective observational pilot study.

- Leidel BA, Kirchoff C, Bogner V, et al.

View Study

Clinical Study

Proximal humerus intraosseous infusion: a preferred emergency venous access.

- Paxton JH, Knuth TE, Klausner HA.

View Study

Clinical Study

The intraosseous have it: a prospective observational study of vascular access success rates in patients in extremis using video review.

- Chreiman KM, Dumas RP, Seamon MJ, et al.

View Study

Clinical Study

Moving the needle on time to resuscitation: an EAST prospective multicenter study of vascular access in hypotensive injured patients using trauma video review.

- Dumas RP, Vella MA, Maiga AW, et al.

View Study

References:

  1. Dolister M, Miller S, Borron S, et al. J Vasc Access. 2013;14(3):216-224. Research sponsored by Teleflex Incorporated.
  2. Cooper BR, Mahoney PF, Hodgetts TJ, et al. J R Army Med Corps. 2007;153(4):314-316.
  3. Davidoff J, Fowler R, Gordon D, et al. JEMS. 2005;30(10):s20-s23. Research sponsored by Teleflex Incorporated.
  4. Leidel BA, Kirchhoff C, Bogner V, et al. Resuscitation. 2012;83(1):40-45.
  5. Teleflex Internal Data on File 2018.

Rx Only.
CAUTION:Federal (USA) law restricts this device to sale by or on the order of a physician.

The Arrow™ EZ-IO™ Needle Set is Sterile, Single Use: Do not reuse, reprocess or re-sterilize. Reuse of device creates a potential risk of serious injury and/or infection which may lead to death. Refer to Instructions for Use for complete warnings, indications, contraindications, precautions, and potential complications.

The Arrow™ EZ-IO™ System is indicated for intraosseous access anytime in which vascular access is difficult to obtain in emergent, urgent or medically necessary cases for up to 24 hours. For patients ≥ 12 years old, the device may be extended for up to 48 hours when alternate intravenous access is not available or reliably established.

Teleflex, the Teleflex logo, Arrow, EZ-IO, and The IO You Know are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. MC-009458